©The Author(s) 2024.
World J Clin Cases. Jan 16, 2024; 12(2): 374-382
Published online Jan 16, 2024. doi: 10.12998/wjcc.v12.i2.374
Published online Jan 16, 2024. doi: 10.12998/wjcc.v12.i2.374
Table 1 The summary of patient's clinical symptoms, exam results, considered diagnosis, and treatment
| Time | Initial | 5 d after | 1 month after |
| Neurologic symptom | Mild cognitive impairments | No significant change in MRC grade 3 left lower leg weakness | Changed mental status to comatose |
| MRC grade 3 left lower leg weakness | |||
| MRI | Asymmetric hyperintensities at the bilateral periventricular white matters, basal ganglia, thalamus, cerebral and cerebellar peduncles | No significant change in extent of T2 hyperintense lesion | Reduced extent of T2 hyperintense lesion in right basal ganglia, but increased extent in left hemisphere compressing left lateral ventricle |
| Newly appeared SAH | |||
| Laboratory exams | Slight elevation of WBC in CSF | Nonspecific | Nonspecific |
| Considered diagnoses | Neuro-Behçet’s disease | Neuro-Behçet’s disease | Glioblastoma |
| Lymphoma | |||
| Metastasis | |||
| Treatment | Prednisolone at 1 mg/d for 5 d | None | Supportive care for bacteremia and sepsis |
- Citation: Kim CS, Choi CH, Yi KS, Kim Y, Lee J, Woo CG, Jeon YH. Absence of enhancement in a lesion does not preclude primary central nervous system T-cell lymphoma: A case report. World J Clin Cases 2024; 12(2): 374-382
- URL: https://www.wjgnet.com/2307-8960/full/v12/i2/374.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i2.374